search
Back to results

Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease

Primary Purpose

Adult Polycystic Kidney Disease

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
renal denervation
Sponsored by
Odense University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Adult Polycystic Kidney Disease focused on measuring ADPKD, denervation, renal denervation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pain limiting daily activities in spite of pain killers, ADPKD

Exclusion Criteria:

  • Pregnancy

Sites / Locations

  • Department of NephrologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

immediate renal denervation

delayed renal denervation

Arm Description

immediate renal denervation

delayed renal denervation

Outcomes

Primary Outcome Measures

Pain
Pain from VAS

Secondary Outcome Measures

Quality of Life (QoL)
SF-12v2

Full Information

First Posted
February 12, 2014
Last Updated
February 13, 2014
Sponsor
Odense University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02062671
Brief Title
Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease
Study Type
Interventional

2. Study Status

Record Verification Date
February 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2014 (undefined)
Primary Completion Date
February 2015 (Anticipated)
Study Completion Date
February 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Odense University Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In patients with polycystic kidney disease, pain may be resistant to drug therapy and may reduce quality of life. This study investigate the effect of renal denervation on this pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adult Polycystic Kidney Disease
Keywords
ADPKD, denervation, renal denervation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
immediate renal denervation
Arm Type
Experimental
Arm Description
immediate renal denervation
Arm Title
delayed renal denervation
Arm Type
Active Comparator
Arm Description
delayed renal denervation
Intervention Type
Procedure
Intervention Name(s)
renal denervation
Primary Outcome Measure Information:
Title
Pain
Description
Pain from VAS
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Quality of Life (QoL)
Description
SF-12v2
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
kidney function
Description
creatinine clearance
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pain limiting daily activities in spite of pain killers, ADPKD Exclusion Criteria: Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hans Dieperink, MD
Phone
+4520598851
Email
hans.dieperink@rsyd.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Marie Blicher, MD
Phone
+ 45 65415305
Email
marie.blicher@rsyd.dk
Facility Information:
Facility Name
Department of Nephrology
City
Odense
ZIP/Postal Code
5000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hans Dieperink, MD
Phone
004520598851
Email
Hans.dieperink@rsyd.dk
First Name & Middle Initial & Last Name & Degree
Hans Dieperink, MD

12. IPD Sharing Statement

Learn more about this trial

Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease

We'll reach out to this number within 24 hrs